08.00-10.00

Registration

10.00-12.30

Welcome
……………………
The PC Trexler Lecture

Functional genomics & the normal flora

Intestinal flora composition
E Zoetendal (The Netherlands)

Intestinal flora function
T Midtvedt (Sweden)

Molecular fingerprinting techniques of the intestinal microbiome
L Engstrand (Sweden)

G Donelli
E Norin
……………………
P Carter
F Bäckhed

13.30-15.30

Understanding the microbial-mammalian cross-talk
J Nicholson (UK)

Microbial bile acid metabolism
P Hylemon (USA))

Microbial nitrogen metabolism
J Lundberg (Sweden)

Lecturers to be announced later

I Rowland
J-Å Gustafsson

16.00-18.00

Intestinal disturbances

Helicobacter pylori – present state of the art
T Wadström (Sweden)

IBD/IBS – animal models
S Pettersson (Sweden)

Lecturers to be announced later

A Ouwehand
L Engstrand

08.30-10.30

Immunology

The hygien hypothesis - revised
B Björkstén (Sweden)

Atophy and allergy in 5 different EU countries – functional aspects
C Edwards (UK)

S. aureus and its superantigens – state of the art
A Wold (Sweden)

To be announced later

J Bienenstock
E Norin

11.00-13.00

Innate immunity & intestinal peptides

Intestinal antimicrobial peptides
K Pütsep (Sweden)

Intestinal microbial peptides
J Bienenstoch (Canada)

Microbial – antimicrobial compounds
M Mikelsaar (Estonia)

To be announced later

G Donelli/R Möllby

14.00-16.00

Obesity – pediatric aspects
C Marcus (Sweden)

Obesity – microbial aspects
F Bäckhed (Sweden)

To be announced later

Zeotendal/K Pütsep

16.30-18.30

Cancer and steroid receptors – state of the art
J-Å Gustafsson (Sweden)

Prostate cancer – state of animal models
M Pollard (USA)
Microbial products and Cancer coli – state of the art
I Rowland (UK)

Efficacy of immunoglobulin for infections
T Masaoka (Japan)

B Shenderov
I Ernberg

08.30-10.30

Antibiotics and gene transfer

GMOs – a hazard to whom

Probiotic GMOs – when will we see them
Lecture from a leading probiotic company

Intestinal gene transfer
T Midtvedt (Sweden)

Antibiotics and alterations in flora composition
C-E Nord (Sweden)

T cell activation by bacterial superantigen
A Wold (Sweden)

S Kamiya
B. Jacobsen

11.00-13.00

Biofilm and medical relevance

Biofilm in the oral cavity
I Olsen (Norway)

Biofilm in the GI ract
U Römling (Sweden)

To be announced later

Industry representative
T Wadström

14.00-16.00

Pre- & Probiotics

Pre-probiotics – State of the art
Industry representative

Regulation and scientific substantiation of health claims
N-G Asp (Sweden)

Rules from regulatory agencies – Japan
S Kamaiya (Japan)

Rules from regulatory agencies – Russia
B Schenderov (Russia)

Rules from regulatory agencies – Western hemisphere
L Vieira (Brazil)

I Olsen
T Midtvedt